Elk Creek Partners, LLC - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 196 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.

Quarter-by-quarter ownership
Elk Creek Partners, LLC ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2020$7,441,000
-33.9%
118,188
+30.2%
1.28%
-1.2%
Q4 2019$11,252,000
+5.1%
90,804
-43.7%
1.29%
+40.5%
Q3 2019$10,711,000
-48.8%
161,406
-22.3%
0.92%
-47.0%
Q4 2018$20,930,000
-29.3%
207,657
-11.3%
1.74%
+8.8%
Q3 2018$29,585,000
-8.8%
234,135
-39.4%
1.60%
-10.5%
Q2 2018$32,423,000
+51.2%
386,397
+10.9%
1.78%
+42.5%
Q1 2018$21,437,000348,4541.25%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q1 2020
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 185,781$4,611,56512.16%
Samsara BioCapital, LLC 640,688$11,878,3563.64%
ALPINE ASSOCIATES MANAGEMENT INC. 2,203,295$40,849,0892.14%
Versor Investments LP 378,480$7,017,0191.42%
Magnetar Financial LLC 2,407,209$44,629,6551.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,077,893$38,524,1360.85%
Fort Baker Capital Management LP 430,600$7,983,3240.74%
EHP Funds Inc. 84,210$1,561,2530.73%
Terrapin Asset Management, LLC 30,000$556,2000.63%
AQR Arbitrage LLC 734,970$13,626,3440.61%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders